Drug approved in Argentina for treatment of Chagas disease in children

Buenos Aires, Argentina – 13 April 2018
Argentina has approved the paediatric indication of a drug used for treatment of Chagas disease, benznidazole, which will now be available in 12.5 mg pills, the dose required to treat children under the age of 2. The indication was approved by the Argentinian National Administration for Drugs, Food, and Medical Technologies (ANMAT).

Affordable Medicines Now

27-29 June 2018
Washington DC, USA
Rachel Cohen, Regional Executive Director – session on global struggles for affordable medicines

ISNTD 2018

25-26 June 2018 
London, UK
Ivan Scandale, Senior Project Manager, Discovery – presentation on the filarial research landscape
Eric StobbaertsInternational Development Director – presentation on access to Chagas treatments in Latin America

DIA Europe 2018

17-19 April 2018
Basel, Switzerland

Nathalie Strub-Wourgraft, DNDi Medical Director – Member of multi-stakeholder panel: “Towards access 2030: How can strengthening of regulatory systems contribute?”